Live
LabiotechBlockbuster sales, lawsuits, and approvals: is there a recovery in sight for Bayer in 2026?FierceBiotechLilly preps for ph. 2 launch after Verve gene editor cuts cholesterol on par with PCSK9 inhibitorsIlluminaIllumina, Inc. (ILMN) Stock Analysis: Navigating the Genetic Sequencing Giant’s Potential with a 33.82% ROE - DirectorsTalk InterviewsCytiva (Google News)Cytiva introduces next-gen Biacore 8 series SPR systems for drug discovery - BioSpectrum AsiaCytiva (Google News)Cytiva introduces next-gen Biacore 8 series SPR systems for drug discovery - BioSpectrum AsiaQiagenQiagen N.V. stock (NL0012169213): Jefferies trims target while shares edge higher - AD HOC NEWSMedtronicMedtronic Clinical Research Freshers Job 2026 – Apply for The Role - BioTecNikaFritsch GmbHLaboratory Mills Market Growth Outlook to 2035: Automation and Nanomaterials Fuel Demand - News and Statistics - IndexBoxMettler ToledoMettler-Toledo stock (US5926881054): laboratory specialist steadies after earnings-driven volatility - AD HOC NEWS10x Genomics BlogIs 10x Genomics (TXG) Quietly Recasting Its Product-Led Story After a Mixed Q1 Beat? - simplywall.st10x Genomics News10x Genomics Inc Class A Trade Ideas — LS:A2PPQJ - TradingViewEvery GreenThe MLB standings are lying to you with a third of the season gone - FanSided
Illumina Apr 9, 2026

Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026 - Yahoo Finance

Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026 - Yahoo Finance

Original
Body unavailable. Use the original source.